Perceptive Advisors »

Inhibikase Therapeutics shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.8M 5.4M 1.62
2025-06-30 $11M 5.4M 1.95
2025-03-31 $13M 5.9M 2.19
2024-12-31 $19M 5.9M 3.25